Copyright © 1996 by the European Society of Cardiology.
© 1996 The European Society of Cardiology
Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure
Department of Internal Medicine, University Hospital Nijmegen, The Netherlands
*Department of Internal Medicine, St Joseph Hospital Veldhoven, The Netherlands
Received 23 February 1996; accepted 28 February 1996.
Correspondence: Tom Dormans, Department of Internal Medicine, University Hospital Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
Abstract
OBJECTIVE: We studied the synergism between high-dose furosemide and hydrochlorothiazide in patients with severe congestive heart failure and impaired renal function showing diuretic resistance to a daily dose of furosemide of at least 250 mg.
DESIGN AND SETTING: An open study A general hospital in The Netherlands.
METHODS: In 20 patients with severe congestive heart failure (stage III–IV according to the New York Heart Association) with an oedematous mass of more than 5 kg and a proven diuretic resistance to high-dose furosemide, hydrochlorothiazide (25–100 mg daily) was added to the medication for 3–12 days, leaving the other medication unchanged. After correction of the hydration state, hydrochlorothiazide was withdrawn. Variables included body weight, serum electrolytes, renal function and natriuresis.
RESULTS: Addition of hydrochlorothiazide resulted in a mean (± standard deviation) body weight reduction of 6.7 ± 3.3 kg per patient. Mean daily urine volume increased from 1899 ± 958 ml to 3065 ± 925 ml (P<0.001). Fractional sodium excretion increased significantly from 3.5 ± 3.2% to 11.5 ± 9.0% (P<0.001). The most important side effect of this combination therapy appeared to be hypokalaemia. Mean endogenous creatinine clearance decreased (not significantly) from 32.7 ± 22.5 ml . min–1 . 1.73 m–2 to 27.6 ± 22.5 ml . min–1. 1.73 m–2
CONCLUSIONS: Addition of hydrochlorothiazide to high-dose furosemide is a powerful diuretic tool, even in patients with a significantly reduced renal function. Because of its potentially dangerous side effects (hypokalaemia), it should be used in a carefully controlled setting.
Key Words: Diuretics • diuretic resistance • oedema • furosemide • heart failure • hydrochlorothiazide
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Valchanov and J. Parameshwar Inpatient management of advanced heart failure CEACCP, October 1, 2008; 8(5): 167 - 171. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Libetta, V. Sepe, M. Zucchi, P. Pisacco, L. Cosmai, F. Meloni, C. Campana, T. Rampino, C. Monti, L. Tavazzi, et al. Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines Nephrol. Dial. Transplant., July 1, 2007; 22(7): 2013 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Paterna, P. Di Pasquale, G. Parrinello, E. Fornaciari, F. Di Gaudio, S. Fasullo, M. Giammanco, F. M. Sarullo, and G. Licata Changes in Brain Natriuretic Peptide Levels and Bioelectrical Impedance Measurements After Treatment With High-Dose Furosemide and Hypertonic Saline Solution Versus High-Dose Furosemide Alone in Refractory Congestive Heart Failure: A Double-Blind Study J. Am. Coll. Cardiol., June 21, 2005; 45(12): 1997 - 2003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S U Shah, S Anjum, and W A Littler Use of diuretics in cardiovascular diseases: (1) heart failure Postgrad. Med. J., April 1, 2004; 80(942): 201 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L K M De Bruyne Mechanisms and management of diuretic resistance in congestive heart failure Postgrad. Med. J., May 1, 2003; 79(931): 268 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Kalra, C. Anagnostopoulos, A. P. Bolger, A. J. S. Coats, and S. D. Anker The regulation and measurement of plasma volume in heart failure J. Am. Coll. Cardiol., June 19, 2002; 39(12): 1901 - 1908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Paterna, P. Di Pasquale, G. Parrinello, P. Amato, A. Cardinale, G. Follone, A. Giubilato, and G. Licata Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure Eur J Heart Fail, September 1, 2000; 2(3): 305 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gellai, G. F. Schreiner, R. R. Ruffolo Jr., T. Fletcher, R. DeWolf, and D. P. Brooks CVT-124, a Novel Adenosine A1 Receptor Antagonist with Unique Diuretic Activity J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1191 - 1196. [Abstract] [Full Text]
|
|